These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20692738)

  • 1. Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2.
    Giordano C; Sansone A; Masi A; Lucente G; Punzi P; Mollica A; Pinnen F; Feliciani F; Cacciatore I; Davis P; Lai J; Ma SW; Porreca F; Hruby V
    Eur J Med Chem; 2010 Oct; 45(10):4594-600. PubMed ID: 20692738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation.
    Keller M; Boissard C; Patiny L; Chung NN; Lemieux C; Mutter M; Schiller PW
    J Med Chem; 2001 Nov; 44(23):3896-903. PubMed ID: 11689075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antinociceptive activity of cyclic endomorphin-2 and morphiceptin analogs.
    Janecka A; Fichna J; Kruszynski R; Sasaki Y; Ambo A; Costentin J; do-Rego JC
    Biochem Pharmacol; 2005 Dec; 71(1-2):188-95. PubMed ID: 16288997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel peripherally active morphiceptin analogs.
    Gach K; do-Rego JC; Fichna J; Storr M; Delbro D; Toth G; Janecka A
    Peptides; 2010 Aug; 31(8):1617-24. PubMed ID: 20434497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endomorphin 1[psi] and endomorphin 2[psi], endomorphins analogues containing a reduced (CH2NH) amide bond between Tyr1 and Pro2, display partial agonist potency but significant antinociception.
    Zhao QY; Chen Q; Yang DJ; Feng Y; Long Y; Wang P; Wang R
    Life Sci; 2005 Jul; 77(10):1155-65. PubMed ID: 15878600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid peptides endomorphin-2/DAMGO: design, synthesis and biological evaluation.
    Mollica A; Costante R; Stefanucci A; Pinnen F; Luisi G; Pieretti S; Borsodi A; Bojnik E; Benyhe S
    Eur J Med Chem; 2013 Oct; 68():167-77. PubMed ID: 23974016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues: part 2.
    Mollica A; Pinnen F; Stefanucci A; Mannina L; Sobolev AP; Lucente G; Davis P; Lai J; Ma SW; Porreca F; Hruby VJ
    J Med Chem; 2012 Oct; 55(19):8477-82. PubMed ID: 22966938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship, conformation and pharmacology studies of morphiceptin analogues--selective mu-opioid receptor ligands.
    Janecka A; Fichna J; Mirowski M; Janecki T
    Mini Rev Med Chem; 2002 Dec; 2(6):565-72. PubMed ID: 12370041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of cyclic endomorphin-2 analogs.
    Perlikowska R; do-Rego JC; Cravezic A; Fichna J; Wyrebska A; Toth G; Janecka A
    Peptides; 2010 Feb; 31(2):339-45. PubMed ID: 19995587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of novel morphiceptin analogues modified in position 3 and their binding to mu-opioid receptors in experimental mammary adenocarcinoma.
    Janecka A; Fichna J; Wiercioch R; Mirowski M
    Bioorg Med Chem; 2003 Sep; 11(18):3855-60. PubMed ID: 12927845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endomorphin-1 analogues containing beta-proline are mu-opioid receptor agonists and display enhanced enzymatic hydrolysis resistance.
    Cardillo G; Gentilucci L; Qasem AR; Sgarzi F; Spampinato S
    J Med Chem; 2002 Jun; 45(12):2571-8. PubMed ID: 12036366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues.
    Mollica A; Pinnen F; Stefanucci A; Feliciani F; Campestre C; Mannina L; Sobolev AP; Lucente G; Davis P; Lai J; Ma SW; Porreca F; Hruby VJ
    J Med Chem; 2012 Apr; 55(7):3027-35. PubMed ID: 22394120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid receptor binding and in vivo antinociceptive activity of position 3-substituted morphiceptin analogs.
    Fichna J; do-Rego JC; Costentin J; Chung NN; Schiller PW; Kosson P; Janecka A
    Biochem Biophys Res Commun; 2004 Jul; 320(2):531-6. PubMed ID: 15219861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphiceptin and beta-casomorphin-5 analogues containing a reduced peptide bond: selective mu-receptor agonists and a novel mu antagonist, H-Tyr-Pro psi (CH2-NH)Phe-Pro-Gly-OH.
    Delaet NG; Verheyden PM; Tourwe D; Van Binst G; Davis P; Burks TF
    Biopolymers; 1992 Aug; 32(8):957-69. PubMed ID: 1330047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and analgesic activities of endomorphin-2 and its analogues.
    Shi ZH; Wei YY; Wang CJ; Yu L
    Chem Biodivers; 2007 Mar; 4(3):458-67. PubMed ID: 17372948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid receptor binding and antinociceptive activity of the analogues of endomorphin-2 and morphiceptin with phenylalanine mimics in the position 3 or 4.
    Gao Y; Liu X; Liu W; Qi Y; Liu X; Zhou Y; Wang R
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3688-92. PubMed ID: 16682191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structure.
    Fichna J; do-Rego JC; Janecki T; Staniszewska R; Poels J; Broeck JV; Costentin J; Schiller PW; Janecka A
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1350-3. PubMed ID: 18207400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inverse type II β-turn on D-Trp-Phe, a pharmacophoric motif for MOR agonists.
    Gentilucci L; Tolomelli A; De Marco R; Spampinato S; Bedini A; Artali R
    ChemMedChem; 2011 Sep; 6(9):1640-53. PubMed ID: 21721130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dmt1, d-1-Nal3]morphiceptin, a novel opioid peptide analog with high analgesic activity.
    Fichna J; do-Rego JC; Chung NN; Costentin J; Schiller PW; Janecka A
    Peptides; 2008 Apr; 29(4):633-8. PubMed ID: 18234394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endomorphin 2 analogues containing Dmp residue as an aromatic amino acid surrogate with high mu-opioid receptor affinity and selectivity.
    Sasaki Y; Sasaki A; Niizuma H; Goto H; Ambo A
    Bioorg Med Chem; 2003 Mar; 11(5):675-8. PubMed ID: 12537996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.